Next, to examine whether VJ can overcome aberrant expression of AKT in CRC cells, we treated HCT transfectants (pCMV/HCT 116 and AKT-6/HCT 116; AKT-12/HCT 116 clones) with VJ. The gene discussed is AKT1; the disease is colorectal carcinoma.